Posttherapy Imaging of Musculoskeletal Neoplasms
Radiologic Clinics of North America, ISSN: 0033-8389, Vol: 49, Issue: 6, Page: 1307-1323
2011
- 24Citations
- 64Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations24
- Citation Indexes24
- 24
- CrossRef14
- Captures64
- Readers64
- 64
Review Description
Posttreatment imaging is important to ensure early detection of oncological complications, and appropriate timing and frequency is an important consideration, especially in high-risk patients. Focused magnetic resonance (MR) imaging is the preferred modality for detection of local recurrence of soft tissue tumors and is also used in high-risk osteosarcoma. Although posttreatment changes can mimic or obscure local recurrence on MR imaging, a systematic approach and knowledge of the features of recurrence versus therapeutic change allows differentiation in almost all cases. Positron emission tomography/computed tomography is also emerging as an important problem-solving tool in local recurrence and in metastatic surveillance. © 2011 Elsevier Inc.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0033838911001321; http://dx.doi.org/10.1016/j.rcl.2011.07.011; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=82455162821&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/22024300; https://linkinghub.elsevier.com/retrieve/pii/S0033838911001321; https://dx.doi.org/10.1016/j.rcl.2011.07.011
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know